EMR vs AMAT vs LRCX vs HON

For growth investors, Lam Research Corporation (LRCX) is the stronger pick with 23.

7% revenue growth year-over-year, versus 3. 0% for Emerson Electric Co. (EMR). Honeywell International Inc. (HON) offers the better valuation at 29. 4x trailing P/E (20. 5x forward), making it the more compelling value choice. Analysts rate Emerson Electric Co. (EMR) a "Buy" — based on 41 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Honeywell International Inc.

(HON) is the cheapest at 29. 4x versus Lam Research Corporation at 69. 0x. On forward P/E, Honeywell International Inc. is actually cheaper at 20. 5x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Applied Materials, Inc. wins at 2. 16x versus Honeywell International Inc. 's 11. 18x.

Over the past 5 years, Lam Research Corporation (LRCX) delivered a total return of +360.

5%, compared to +3. 3% for Honeywell International Inc. (HON). Over 10 years, the gap is even starker: LRCX returned +38. 2% versus HON's +135. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Honeywell International Inc.

(HON) is the lower-risk stock at 0. 74β versus Lam Research Corporation's 2. 54β — meaning LRCX is approximately 243% more volatile than HON relative to the S&P 500. On balance sheet safety, Applied Materials, Inc. (AMAT) carries a lower debt/equity ratio of 32% versus 2% for Honeywell International Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Lam Research Corporation (LRCX) is pulling ahead at 23.

7% versus 3. 0% for Emerson Electric Co. (EMR). On earnings-per-share growth, the picture is similar: Lam Research Corporation grew EPS 43. 1% year-over-year, compared to -15. 5% for Honeywell International Inc.. Over a 3-year CAGR, EMR leads at 9. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Lam Research Corporation (LRCX) is the more profitable company, earning 29.

1% net margin versus 12. 6% for Honeywell International Inc. — meaning it keeps 29. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LRCX leads at 32. 0% versus 17. 5% for HON. At the gross margin level — before operating expenses — EMR leads at 52. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Applied Materials, Inc. (AMAT) is the more undervalued stock at a PEG of 2. 16x versus Honeywell International Inc. 's 11. 18x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Honeywell International Inc. (HON) trades at 20. 5x forward P/E versus 50. 7x for Lam Research Corporation — 30. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EMR: 14. 8% to $161. 92.

All stocks in this comparison pay dividends.

Honeywell International Inc. (HON) offers the highest yield at 2. 1%, versus 0. 3% for Lam Research Corporation (LRCX).

For long-horizon retirement investors, Honeywell International Inc.

(HON) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 74), 2. 1% yield, +135. 1% 10Y return). Applied Materials, Inc. (AMAT) carries a higher beta of 2. 14 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HON: +135. 1%, AMAT: +20. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (EMR (Industrials) and AMAT (Technology) and LRCX (Technology) and HON (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: EMR is a mid-cap quality compounder stock; AMAT is a large-cap quality compounder stock; LRCX is a large-cap high-growth stock; HON is a mid-cap quality compounder stock. EMR, HON pay a dividend while AMAT, LRCX do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.